UnitedHealth Group Incorporated $UNH Shares Sold by Coppell Advisory Solutions LLC

Coppell Advisory Solutions LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 65.8% during the second quarter, Holdings Channel.com reports. The firm owned 1,686 shares of the healthcare conglomerate’s stock after selling 3,247 shares during the period. Coppell Advisory Solutions LLC’s holdings in UnitedHealth Group were worth $521,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC lifted its stake in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC boosted its holdings in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares in the last quarter. Forvis Mazars Wealth Advisors LLC raised its stake in UnitedHealth Group by 2.3% during the 1st quarter. Forvis Mazars Wealth Advisors LLC now owns 3,320 shares of the healthcare conglomerate’s stock worth $1,739,000 after acquiring an additional 75 shares in the last quarter. LeConte Wealth Management LLC purchased a new position in shares of UnitedHealth Group during the first quarter worth about $338,000. Finally, George Kaiser Family Foundation lifted its holdings in shares of UnitedHealth Group by 135.5% in the 1st quarter. George Kaiser Family Foundation now owns 1,100 shares of the healthcare conglomerate’s stock valued at $576,000 after purchasing an additional 633 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH opened at $341.83 on Monday. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The company has a 50-day simple moving average of $339.84 and a 200-day simple moving average of $317.20. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36. The company has a market capitalization of $309.65 billion, a PE ratio of 17.84, a P/E/G ratio of 2.23 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period last year, the company posted $7.15 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be given a $2.21 dividend. The ex-dividend date is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Morgan Stanley boosted their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. UBS Group increased their price target on shares of UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. JPMorgan Chase & Co. upped their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Finally, Jefferies Financial Group lifted their target price on UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research note on Friday, October 17th. Seventeen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Hold” and a consensus price target of $385.54.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.